Lopinavir/ritonavir or Efavirenz containing antiretroviral therapy regimen on the pharmacokinetics of etonogestrel-releasing implant in HIV-positive women

Trial Profile

Lopinavir/ritonavir or Efavirenz containing antiretroviral therapy regimen on the pharmacokinetics of etonogestrel-releasing implant in HIV-positive women

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Dec 2015

At a glance

  • Drugs Efavirenz (Primary) ; Lopinavir/ritonavir (Primary)
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 29 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top